Latest snapshot of the coronavirus impact

LATEST COVID-19 DEVELOPMENTS * The federal government has stuck by its time frame for the COVID-19 vaccination rollout despite initial delays, with administered doses falling well short of the 60,000 nationwide target for the first week. * As of Tuesday, nearly 42,000 first-dose vaccinations have taken place. * The federal government has also insisted the… Read More »

FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A

FDA Approves Nulibry (fosdenopterin) to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency (MoCD) Type A PALO ALTO, February 28, 2021 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio) and affiliate Origin Biosciences, Inc. (Origin) today announced the U.S. Food and Drug Administration (FDA) has approved Nulibry (fosdenopterin) for Injection as the first… Read More »